The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological Implications
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological Implications
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 22, Pages 5683
Publisher
MDPI AG
Online
2019-11-13
DOI
10.3390/ijms20225683
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Obesity as a tumour development triggering factor
- (2019) Agnieszka Budny et al. ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE
- The influence of obesity-related factors in the etiology of renal cell carcinoma—A mendelian randomization study
- (2019) Mattias Johansson et al. PLOS MEDICINE
- Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of body mass index (BMI) on treatment outcomes to immune checkpoint blockade (ICB) in metastatic renal cell carcinoma (mRCC).
- (2019) Aly-Khan A. Lalani et al. JOURNAL OF CLINICAL ONCOLOGY
- Body mass index (BMI) and toxicities and association with clinical outcomes (CO) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (cabo).
- (2019) Dylan J Martini et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating obesity-driven biomarkers are associated with risk of clear cell renal cell carcinoma: a two-stage, case-control study
- (2019) Qinchuan Wang et al. CARCINOGENESIS
- Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab
- (2019) Ugo De Giorgi et al. CLINICAL CANCER RESEARCH
- Novel risk stratification criteria of metastatic renal cell carcinoma (mRCC) patients (pts) treated with immune checkpoint inhibitors (ICI).
- (2019) Dylan J Martini et al. JOURNAL OF CLINICAL ONCOLOGY
- Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers
- (2019) Matteo Santoni et al. Cancers
- Gut microbiota and obesity: Concepts relevant to clinical care
- (2018) Maria Carlota Dao et al. European Journal of Internal Medicine
- Obesity and Cancer: Existing and New Hypotheses for a Causal Connection
- (2018) Trevor W. Stone et al. EBioMedicine
- Circulating Adipose Fatty Acid Binding Protein Is a New Link Underlying Obesity-Associated Breast/Mammary Tumor Development
- (2018) Jiaqing Hao et al. Cell Metabolism
- A-FABP links obesity and breast cancer
- (2018) Claire Greenhill Nature Reviews Endocrinology
- Energy balance and gastrointestinal cancer: risk, interventions, outcomes and mechanisms
- (2018) Cornelia M. Ulrich et al. Nature Reviews Gastroenterology & Hepatology
- Impact of baseline visceral fat accumulation on prognosis in patients with metastatic renal cell carcinoma treated with systemic therapy
- (2017) Ryuichi Mizuno et al. MEDICAL ONCOLOGY
- Kidney cancer: Methylation of obesity-related genes is associated with prognosis
- (2017) Peter Sidaway Nature Reviews Urology
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Vital Signs: Trends in Incidence of Cancers Associated with Overweight and Obesity — United States, 2005–2014
- (2017) C. Brooke Steele et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Non-glycanated Decorin Is a Drug Target on Human Adipose Stromal Cells
- (2017) Alexes C. Daquinag et al. Molecular Therapy-Oncolytics
- The impact of body mass index (BMI) and body surface area (BSA) on treatment outcome to vascular endothelial growth factor (VEGF)-targeted therapy in metastatic renal cell carcinoma: Results from a large international collaboration.
- (2017) T. K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolic phenotype of bladder cancer
- (2016) Francesco Massari et al. CANCER TREATMENT REVIEWS
- Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database
- (2016) Lindsay A. Renfro et al. JOURNAL OF CLINICAL ONCOLOGY
- Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations
- (2016) Laurence Albiges et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted Proapoptotic Peptides Depleting Adipose Stromal Cells Inhibit Tumor Growth
- (2016) Alexes C Daquinag et al. MOLECULAR THERAPY
- Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment
- (2016) Hiroki Ishihara et al. Targeted Oncology
- cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer
- (2016) Alyssa J. Cozzo et al. SpringerPlus
- Molecular Pathways: Trafficking of Metabolic Resources in the Tumor Microenvironment
- (2015) I. L. Romero et al. CLINICAL CANCER RESEARCH
- Metabolic functions of FABPs—mechanisms and therapeutic implications
- (2015) Gökhan S. Hotamisligil et al. Nature Reviews Endocrinology
- Adiponectin inhibits VEGF-A in prostate cancer cells
- (2015) Qiruo Gao et al. TUMOR BIOLOGY
- Idiopathic renal replacement lipomatosis: A rare renal pseudo tumor
- (2014) ShailjaP Wahal et al. Journal of Cancer Research and Therapeutics
- Handling and Staging of Renal Cell Carcinoma
- (2013) Kiril Trpkov et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
- (2013) John R. Srigley et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- An Epidemiologic and Genomic Investigation Into the Obesity Paradox in Renal Cell Carcinoma
- (2013) A. Ari Hakimi et al. JNCI-Journal of the National Cancer Institute
- Metabolic Factors Associated with Risk of Renal Cell Carcinoma
- (2013) Christel Häggström et al. PLoS One
- Obesity and Prostate Cancer: Weighing the Evidence
- (2012) Emma H. Allott et al. EUROPEAN UROLOGY
- Does overweight influence the prognosis of renal cell carcinoma? Results of a multicenter study
- (2012) Sandra Steffens et al. INTERNATIONAL JOURNAL OF UROLOGY
- Does Obesity Influence the Prognosis of Metastatic Renal Cell Carcinoma in Patients Treated with Vascular Endothelial Growth Factor-Targeted Therapy?
- (2011) S. Steffens et al. ONCOLOGIST
- Visceral Fat Area as a New Independent Predictive Factor of Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Antiangiogenic Agents
- (2011) S. Ladoire et al. ONCOLOGIST
- Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients
- (2009) K. Hancke et al. BREAST CANCER RESEARCH AND TREATMENT
- Renal Sinus Fat Invasion in pT3a Clear Cell Renal Cell Carcinoma Affects Outcomes of Patients Without Nodal Involvement or Distant Metastases
- (2009) Roberto Bertini et al. JOURNAL OF UROLOGY
- Advances and controversies in grading and staging of renal cell carcinoma
- (2009) Brett Delahunt MODERN PATHOLOGY
- Body Size and Renal Cell Cancer Incidence in a Large US Cohort Study
- (2008) Kenneth F. Adams et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Fatty Acid Synthase Over Expression is an Indicator of Tumor Aggressiveness and Poor Prognosis in Renal Cell Carcinoma
- (2008) Akio Horiguchi et al. JOURNAL OF UROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started